EGRX - SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals Inc.(EGRX) Investors of a Class Action Lawsuit and Upcoming Deadline | Benzinga

NEW YORK, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Eagle Pharmaceuticals, Inc. ("Eagle Pharmaceuticals" or the "Company") (NASDAQ:EGRX) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Eagle Pharmaceuticals investors who were adversely affected by alleged securities fraud between August 8, 2023 and November 28, 2023. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/eagle-pharmaceuticals-inc-lawsuit-submission-form?prid=60201&wire=3

EGRX investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) that ...

EGRX) Investors of a Class Action Lawsuit and Upcoming Deadline>Full story available on Benzinga.com